A Study of People With CD30 Positive Lymphoma in China
Clinical trial NCT05506774 · COMPLETED
Trial details
- NCT number
- NCT05506774
- Sponsor
- Takeda
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-02-28
- Primary completion
- 2024-07-03
- Enrollment
- 1006
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.